| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| alendronic acid | v-type proton atpase catalytic subunit a | small molecule | NA | drugbank | Osteoporosis[MeSHID:D010024] Osteitis Deformans[MeSHID:D010001] |
NA | approved | inhibitor |
| alendronic acid | farnesyl pyrophosphate synthase | small molecule | NA | drugbank | Osteoporosis[MeSHID:D010024] Osteitis Deformans[MeSHID:D010001] |
NA | approved | inhibitor |
| alendronic acid | tyrosine-protein phosphatase non-receptor type 4 | small molecule | NA | drugbank | Osteoporosis[MeSHID:D010024] Osteitis Deformans[MeSHID:D010001] |
NA | approved | inhibitor |
| alendronic acid | receptor-type tyrosine-protein phosphatase epsilon | small molecule | NA | drugbank | Osteoporosis[MeSHID:D010024] Osteitis Deformans[MeSHID:D010001] |
NA | approved | inhibitor |
| alendronic acid | receptor-type tyrosine-protein phosphatase s | small molecule | NA | drugbank | Osteoporosis[MeSHID:D010024] Osteitis Deformans[MeSHID:D010001] |
NA | approved | inhibitor |
| alendronic acid | hydroxylapatite | small molecule | NA | drugbank | Osteoporosis[MeSHID:D010024] Osteitis Deformans[MeSHID:D010001] |
NA | approved | antagonist |
| click here to return to the previous page | ||||||||